Back to search
FDAFDA · Food and drugs·Recall number D-1537-2014

Depo-Medrol (methylprednisolone acetate injectable suspension USP), 40 mg/ mL, 1 mL Single-Dose Vial, Rx only, Distributed by Pharmacia & Upjohn Co Division of Pfizer Inc, New York NY 10017 NDC 0009-3073-03 DEPO-MEDROL methylprednisolone acetate Injectable Suspension USP, 40 mg per mL, 1 mL Single-Dose Vial, Rx ONLY, Distributed by Pharmacia & Upjohn Co Division of Pfizer Inc, New York NY 10017, NOVAPLUS is a registered trademark of Novation, LLC NDC 0009-3073-23

Published August 20, 2014 · Recall initiated: July 30, 2014

Summary

FDA records drug Class III recall D-1537-2014, published August 20, 2014 and initiated July 30, 2014. Recalling firm: Pfizer Inc.; Status: Terminated; Reported quantity: 93,800 vials; Lot: Lot H43272, H43265 Exp. 09/14. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed pH Specification: A pH result of 2.9 was obtained at the 9 month stability test interval at 25C/60%RH. The registered specification for pH is 3.0 - 7.0

What to do

Voluntary: Firm initiated · Letter

Get an email if DEPO-MEDROL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DEPO-MEDROL
Manufacturer
Pfizer Inc.
Distributor
Nationwide
Lot
Lot H43272, H43265 Exp. 09/14
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Depo-Medrol (methylprednisolone acetate injectable suspension USP), 40 mg/ mL, 1 mL Single-Dose Vial, Rx only, Distributed by Pharmacia & Upjohn Co Division of Pfizer Inc, New York NY 10017 NDC 0009-3073-03 DEPO-MEDROL methylprednisolone acetate Injectable Suspension USP, 40 mg per mL, 1 mL Single-Dose Vial, Rx ONLY, Distributed by Pharmacia & Upjohn Co Division of Pfizer Inc, New York NY 10017, NOVAPLUS is a registered trademark of Novation, LLC NDC 0009-3073-23 recalled?

Yes. FDA published recall D-1537-2014 on August 20, 2014. Reported hazard: Failed pH Specification: A pH result of 2.9 was obtained at the 9 month stability test interval at 25C/60%RH. The registered specification for pH is 3.0 - 7.0

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DEPO-MEDROL.